Global Heart-on-a-chip Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends
Publisher : MRA | Format : PDF
Global Heart-on-a-chip Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
By "Heart-on-a-chip" technology - simulating the human heart on an engineering chip and using microelectrodes to measure the effects of compound exposure, it is possible to ensure that potential life-saving new drugs are safe and effective, while reducing the need for humans and animal testing.
Heart-on-a-chip report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global Heart-on-a-chip market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Pharmaceutical & Biotechnology Companies and Academic & Research Institutes are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Heart-on-a-chip industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Heart-on-a-chip key companies include Emulate, Tissuse, Hesperos, CN Bio Innovations, Draper Laboratory, Mimetas, Nortis, Kirkstall and Cherry Biotech SAS, etc. Emulate, Tissuse, Hesperos are top 3 players and held % share in total in 2023.
Heart-on-a-chip can be divided into Children Heart-on-a-chip and Adult Heart-on-a-chip, etc. Children Heart-on-a-chip is the mainstream product in the market, accounting for % share globally in 2023.
Heart-on-a-chip is widely used in various fields, such as Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Other End Users,, etc. Pharmaceutical & Biotechnology Companies provides greatest supports to the Heart-on-a-chip industry development. In 2023, global % share of Heart-on-a-chip went into Pharmaceutical & Biotechnology Companies filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Heart-on-a-chip market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Emulate
Tissuse
Hesperos
CN Bio Innovations
Draper Laboratory
Mimetas
Nortis
Kirkstall
Cherry Biotech SAS
Else Else Kooi Laboratory
Micronit Microtechnologies B.V.
Tara Biosystems
Segment by Type
Children Heart-on-a-chip
Adult Heart-on-a-chip
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Other End Users
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Heart-on-a-chip market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Heart-on-a-chip introduction, etc. Heart-on-a-chip Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of Heart-on-a-chip market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.
Heart-on-a-chip report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global Heart-on-a-chip market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Pharmaceutical & Biotechnology Companies and Academic & Research Institutes are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Heart-on-a-chip industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Heart-on-a-chip key companies include Emulate, Tissuse, Hesperos, CN Bio Innovations, Draper Laboratory, Mimetas, Nortis, Kirkstall and Cherry Biotech SAS, etc. Emulate, Tissuse, Hesperos are top 3 players and held % share in total in 2023.
Heart-on-a-chip can be divided into Children Heart-on-a-chip and Adult Heart-on-a-chip, etc. Children Heart-on-a-chip is the mainstream product in the market, accounting for % share globally in 2023.
Heart-on-a-chip is widely used in various fields, such as Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Other End Users,, etc. Pharmaceutical & Biotechnology Companies provides greatest supports to the Heart-on-a-chip industry development. In 2023, global % share of Heart-on-a-chip went into Pharmaceutical & Biotechnology Companies filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Heart-on-a-chip market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Emulate
Tissuse
Hesperos
CN Bio Innovations
Draper Laboratory
Mimetas
Nortis
Kirkstall
Cherry Biotech SAS
Else Else Kooi Laboratory
Micronit Microtechnologies B.V.
Tara Biosystems
Segment by Type
Children Heart-on-a-chip
Adult Heart-on-a-chip
Segment by Application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Other End Users
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Heart-on-a-chip market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Heart-on-a-chip introduction, etc. Heart-on-a-chip Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of Heart-on-a-chip market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.